References
1. Brinkmann V, Zychlinsky A.
Neutrophil extracellular traps: is immunity the second function of
chromatin? J Cell Biol. 2012;198(5):773-783.
2. Huang C, Wang Y, Li X, et al.
Clinical features of patients infected with 2019 novel coronavirus in
Wuhan, China. Lancet. 2020;395(10223):497-506.
3. Yu N, Li W, Kang Q, et al. Clinical
features and obstetric and neonatal outcomes of pregnant patients with
COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive
study. The Lancet Infectious diseases. 2020.
4. Wang M, Cao R, Zhang L, et al.
Remdesivir and chloroquine effectively inhibit the recently emerged
novel coronavirus (2019-nCoV) in vitro. Cell research.2020;30(3):269-271.
5. Lu H. Drug treatment options for
the 2019-new coronavirus (2019-nCoV). Bioscience trends.2020;14(1):69-71.
6. Singer M, Deutschman CS, Seymour
CW, et al. The Third International Consensus Definitions for Sepsis and
Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
7. Scarlatescu E, Tomescu D, Arama SS.
Anticoagulant Therapy in Sepsis. The Importance of Timing. J Crit
Care Med (Targu Mures). 2017;3(2):63-69.
8. Wu Z, McGoogan JM. Characteristics
of and Important Lessons From the Coronavirus Disease 2019 (COVID-19)
Outbreak in China: Summary of a Report of 72314 Cases From the Chinese
Center for Disease Control and Prevention. Jama. 2020.
9. Channappanavar R, Perlman S.
Pathogenic human coronavirus infections: causes and consequences of
cytokine storm and immunopathology. Seminars in immunopathology.2017;39(5):529-539.
10. Min CK, Cheon S, Ha NY, et al.
Comparative and kinetic analysis of viral shedding and immunological
responses in MERS patients representing a broad spectrum of disease
severity. Scientific reports. 2016;6:25359.
11. Feng Y, Ling Y, Bai T, et al.
COVID-19 with Different Severity: A Multi-center Study of Clinical
Features. American journal of respiratory and critical care
medicine. 2020.
12. Qin C, Zhou L, Hu Z, et al.
Dysregulation of immune response in patients with COVID-19 in Wuhan,
China. Clin Infect Dis. 2020.
13. Wang F, Hou H, Luo Y, et al. The
laboratory tests and host immunity of COVID-19 patients with different
severity of illness. JCI Insight. 2020;5(10).
14. Chen T, Wu D, Chen H, et al.
Clinical characteristics of 113 deceased patients with coronavirus
disease 2019: retrospective study. Bmj. 2020;368:m1091.
15. Wang D, Hu B, Hu C, et al.
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel
Coronavirus-Infected Pneumonia in Wuhan, China. Jama. 2020.
16. Du Y, Tu L, Zhu P, et al.
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan: A
Retrospective Observational Study. American journal of respiratory
and critical care medicine. 2020.
17. Wu C, Chen X, Cai Y, et al. Risk
Factors Associated With Acute Respiratory Distress Syndrome and Death in
Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.JAMA internal medicine. 2020.
18. Baek MS, Lee Y, Hong SB, Lim CM,
Koh Y, Huh JW. Effect of corticosteroid therapy in the early phase of
acute respiratory distress syndrome: a propensity-matched cohort study.The Korean journal of internal medicine. 2020.
19. Tsai MJ, Yang KY, Chan MC, et al.
Impact of corticosteroid treatment on clinical outcomes of
influenza-associated ARDS: a nationwide multicenter study. Annals
of intensive care. 2020;10(1):26.
20. MacLaren G, Fisher D, Brodie D.
Preparing for the Most Critically Ill Patients With COVID-19: The
Potential Role of Extracorporeal Membrane Oxygenation. Jama.2020.
21. Li Y, Cao C, Huang L, et al.
”Awake” extracorporeal membrane oxygenation (ECMO) combined with
continuous renal replacement therapy (CRRT) for the treatment of severe
chemical gas inhalation lung injury. Journal of burn care &
research : official publication of the American Burn Association. 2020.
22. Chen N, Zhou M, Dong X, et al.
Epidemiological and clinical characteristics of 99 cases of 2019 novel
coronavirus pneumonia in Wuhan, China: a descriptive study.Lancet. 2020;395(10223):507-513.
23. Lescure FX, Bouadma L, Nguyen D,
et al. Clinical and virological data of the first cases of COVID-19 in
Europe: a case series. The Lancet Infectious diseases. 2020.
24. Guo YR, Cao QD, Hong ZS, et al.
The origin, transmission and clinical therapies on coronavirus disease
2019 (COVID-19) outbreak - an update on the status. Military
Medical Research. 2020;7(1):11.
25. Alhazzani W, Moller MH, Arabi YM,
et al. Surviving Sepsis Campaign: guidelines on the management of
critically ill adults with Coronavirus Disease 2019 (COVID-19).Intensive Care Med. 2020;46(5):854-887.
26. Murthy S, Gomersall CD, Fowler
RA. Care for Critically Ill Patients With COVID-19. JAMA. 2020.
Table1. Demographics and clinical characteristics of patients